BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 11, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Synapse discovery could lead to new Alzheimer's treatments

Dec. 3, 2015
By John Fox
HONG KONG — Australian researchers led by the University of New South Wales (UNSW) have discovered the mechanism whereby synaptic connections between brain cells are destroyed in the early stages of Alzheimer's disease (AD), a key finding that clears the way for new research on urgently needed treatments for the currently incurable degenerative brain disease.
Read More

First plasmid-mediated colistin resistance reported in China

Dec. 2, 2015
By John Fox
HONG KONG — A new gene conferring resistance to polymyxins, the last antibiotic defense against resistant microorganisms, has been found to be widespread in Enterobacteriaceae from pigs and patients in southern China, raising fears of emergence of strains of gram-negative bacteria with resistance to all currently available antibiotics.
Read More

First plasmid-mediated colistin resistance reported in China

Dec. 1, 2015
By John Fox
HONG KONG – A new gene conferring resistance to polymyxins, the last antibiotic defense against resistant microorganisms, has been found to be widespread in Enterobacteriaceae from pigs and patients in southern China, raising fears of emergence of strains of gram-negative bacteria with resistance to all currently available antibiotics.
Read More

Protocol converts PSCs into functional neurons

Nov. 25, 2015
By John Fox
HONG KONG — Combining suppression of stemness with lineage-specific induction using a newly developed sequential treatment protocol leads to the successful conversion of pluripotent stem cells (PSCs) into functioning neurons for potential use in regenerative medicine, a study by Korean researchers has found.
Read More

Protocol converts PSCs into functional neurons

Nov. 24, 2015
By John Fox
HONG KONG – Combining suppression of stemness with lineage-specific induction using a newly developed sequential treatment protocol leads to the successful conversion of pluripotent stem cells (PSCs) into functioning neurons for potential use in regenerative medicine, a study by Korean researchers has found.
Read More

New cancer biomarkers set to improve diagnosis and treatment

Nov. 18, 2015
By John Fox
HONG KONG – A new collaborative study by the Riken Center for Life Science Technologies (CLST) in Japan and the Harry Perkins Institute for Medical Research in Australia has identified multiple new genes that are up-regulated in different cancer types, opening the door for the development of new biomarker tests for early cancer detection and more effective new treatments.
Read More

Potential new neuroblastoma treatment identified

Nov. 18, 2015
By John Fox
HONG KONG – An Australian study has identified a critical molecular feedback loop that helps initiate and drive neuroblastoma, which may result in a badly needed new treatment strategy for the disease, Sydney Children's Hospital and University of New South Wales (UNSW) researchers reported in the Nov. 4, 2015, issue of Science Translational Medicine.
Read More

Potential new neuroblastoma treatment identified

Nov. 12, 2015
By John Fox
HONG KONG – An Australian study has identified a critical molecular feedback loop that helps initiate and drive neuroblastoma, which may result in a badly needed new treatment strategy for the disease, Sydney Children’s Hospital and University of New South Wales (UNSW) researchers reported in the Nov. 4, 2015, issue of Science Translational Medicine.
Read More

First mouse model of spontaneous depression reveals new brain region

Oct. 28, 2015
By John Fox
HONG KONG — Japanese neurobiologists have used a mouse model of spontaneous depression to demonstrate a link between depression and the paraventricular thalamus, a region of the brain not previously linked to depression, a finding that could lead to the development of new antidepressive therapies.
Read More

First mouse model of spontaneous depression reveals new brain region

Oct. 27, 2015
By John Fox
HONG KONG — Japanese neurobiologists have used a mouse model of spontaneous depression to demonstrate a link between depression and the paraventricular thalamus, a region of the brain not previously linked to depression, a finding that could lead to the development of new antidepressive therapies.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing